US Stocks
/
BriaCell Therapeutics Corp. Warrant expiring 2031 Share Price
BriaCell Therapeutics Corp. Warrant expiring 2031 Share Price

BriaCell Therapeutics Corp. Warrant expiring 2031 Share Price

NASDAQ: BCTXL | Micro Cap
$1.11
-$0.06 (-5.13%) Last updated on 09 Oct, 2026 | 00:39 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BriaCell Therapeutics Corp. Warrant expiring 2031 Stock Performance

Open
$1.11
Prev. Close
$1.17
Circuit Range
N/A
Day Range
$1.11 - $1.11
Year Range
$0.65 - $1.34
Volume
150
Average Traded
$1.11

BriaCell Therapeutics Corp. Warrant expiring 2031 Share Price Today

As of 10 October 2026, BriaCell Therapeutics Corp. Warrant expiring 2031's share price is $1.11. The stock opened at $1.11, compared to its previous close of $1.17. During today's trading session, BriaCell Therapeutics Corp. Warrant expiring 2031's share price traded between $1.11 and $1.11, with an average price of $1.11. Over the past 52 weeks, the stock has recorded a high of $1.34 and a low of $0.65. In terms of performance, BriaCell Therapeutics Corp. Warrant expiring 2031's share price has risen by 7.77% over the last six months and is down 5.13% on a year-on-year basis.

BriaCell Therapeutics Corp. Warrant expiring 2031 Share Price Chart

$1.11$1.11
L
Show Current Price
H

BriaCell Therapeutics Corp. Warrant expiring 2031 Stock Fundamentals & Key Indicators

Market Cap
$469656.54
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
-127.51%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
N/A

BriaCell Therapeutics Corp. Warrant expiring 2031 Quarterly Profit & Loss

All figures in USD

ParticularsJan 2026Apr 2026
Revenue$0.00$0.00
Net Profit-$7.22-$7.16
Net Profit MarginN/AN/A
Income ChangeN/A0.83%

About BriaCell Therapeutics Corp. Warrant expiring 2031

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

BriaCell Therapeutics Corp. Warrant expiring 2031 Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.21
$1.11
-6.72%
Sep 2026
$0.97
$1.19
+38.37%
Jul 2026
$0.89
$0.86
+32.31%
Jun 2026
$0.83
$0.65
-31.58%
May 2026
$0.80
$0.95
-1.04%
Apr 2026
$1.05
$0.96
-6.80%
Mar 2026
$0.99
$1.03
+4.04%
Feb 2026
$1.11
$0.99
-15.38%
Jan 2026
$0.84
$1.17
N/A

BCTXL Share Price FAQs

What is BriaCell Therapeutics Corp. Warrant expiring 2031 share price today?

chevron-up
BriaCell Therapeutics Corp. Warrant expiring 2031 share price today is $1.11 as on October 9, 2026 at 12:39 am IST.

What is the 52 week high and 52 week low of BriaCell Therapeutics Corp. Warrant expiring 2031 stock?

chevron-up
The 52 week high of BriaCell Therapeutics Corp. Warrant expiring 2031 stock is $1.34, while the 52 week low is $0.65 as of 9 Oct '26.

What is BCTXL's market capitalisation today?

chevron-up
BCTXL market capitalisation is $469656.54 as of October 10, 2026, at 12:41 am IST.

What is BCTXL's net income for the last quarter?

chevron-up
BCTXL's net income for the last quarter is -7.16B USD.

What is the 5 year returns of BCTXL?

chevron-up
The 5 year returns of BCTXL is -5.13% as on 9 Oct '26.

What is the high & low stock price of BCTXL today?

chevron-up
BCTXL stock price hit a high of $1.11 and low of $1.11 as of 9 Oct '26.

Can I buy BCTXL shares in India?

chevron-up
Yes. You can buy BCTXL in India by opening an international trading account.